

<html>
<head>
	<link rel="stylesheet" type="text/css" href="/compendium/includes/compendium.css?nocache=020415-192633b8065">
    
	
		<link rel="stylesheet" type="text/css" href="/compendium/includes/compendium-print.css?nocache=020415-192633508b6" media="print">
	
		<script type="text/javascript" src="/_script/disableSelection.js"></script>
	

	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /> 

    <title>TRACE Compendium - TEVA PHARMACEUTICAL INDUSTRIES LIMITED</title>
</head>
<body>


	<script type="text/javascript">
		//prevent simple select/copy
		disableSelection(document.body);
		
		function openPDF(idCase)
		{
			location.href = "pdf.asp?id=" + idCase;
		}
	</script>

	<div onClick="openPDF(427)" id="pdfLink" style="background: #EEE; border: 1px solid #CCC; font-size: 8pt; font-family: Tahoma, Verdana; cursor: pointer; padding: 5px; position: absolute; top: 0px; right: 0px;">
		<img src="/_img/icons/pdf-13x14.gif" width="13" height="14" border="0" align="absbottom" /> View as PDF
	</div>



<div id="contentHome">

    <div id="case">
    
		
        
		<div id="compendiumLogo"><img src="/compendium/includes/logo-compendium.png?nocache=020415-192633209m0" width="415" height="61" /></div>
    
        <h1>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</h1>
        
        <h2>ENFORCEMENT AGENCY</h2>
        United States: Department of Justice<br />United States: Securities and Exchange Commission <br />
        
        <h2>ENTITIES/INDIVIDUALS INVOLVED</h2>
        Teva Pharmaceutical Industries Limited ("Teva")
        
        <h2>DESCRIPTION OF BUSINESS</h2>
        Pharmaceuticals - producer and marketer of generic drugs, innovative and specialty pharmaceuticals and active pharmaceutical ingredients
        
        <h2>CORPORATE HEADQUARTERS</h2>
        Petah Tikva, Israel
        
        <h2>NATIONALITY OF FOREIGN OFFICIALS</h2>
        Unspecified<br />Russia<br />
        
        <h2>SUMMARY OF ALLEGATIONS</h2>
        In its Form 6-K filed with the U.S. Securities and Exchange Commission ("SEC") on 2 August 2012, the company noted that it had received a  subpoena dated July 9, 2012 from the SEC "to produce documents with respect to compliance with the Foreign Corrupt Practice Act ('FCPA') in Latin America."  On 10 October 2012, the DOJ sent informal document requests to Teva.<br /><br />Although the initial SEC and DOJ investigation began due to concerns with the company's practices in Latin America, it appears that the investigations have expanded to include its practices in Eastern Europe as well.  In a SEC Form 6-k filed on 2 May 2014, Teva disclosed that its affiliates in Russia, certain Eastern European countries, certain Latin American countries, and other countries where it does business provided local authorities with inaccurate or altered information relating to the company's marketing or promotional practices.  Teva disclosed in its Form 20-F filed on 9 February 2015 that it had identified practices and transactions in those regions that "likely constitute violations of the FCPA and/or local law."
        
        <h2>RATIO OF IMPROPER PAYMENTS TO BUSINESS ADVANTAGE</h2>
        <table style="height: 53px;" border="1" cellspacing="0" cellpadding="2" width="771">
<tbody>
<tr style="text-align: center;">
<td width="50%"><strong>&nbsp;Approximate Alleged Payments to Foreign Officials<br /></strong></td>
<td width="50%"><strong>&nbsp;Business Advantage Allegedly Obtained<br /></strong></td>
</tr>
<tr style="text-align: center;">
<td>&nbsp;Unspecified</td>
<td>&nbsp;Unspecified</td>
</tr>
</tbody>
</table>
        
        <h2>HOW CONDUCT WAS DISCOVERED</h2>
        Unspecified
        
        <h2>ENFORCEMENT RESULT</h2>
        UNITED STATES<br /><br />Investigations by the DOJ and SEC are ongoing.<br /><br /><br />INTERNAL<br /><br />Teva's internal investigation is ongoing.
        
        <h2>KEY TAKEAWAYS</h2>
        <ul><li>TBD</li></ul>
        
        <h2>RELATED DOCUMENTS</h2>
		<p><a href="file.asp?id=1910">Teva - SEC Form 6-K (2 August 2012)</a></p><p><a href="file.asp?id=2033">TEVA - SEC Form 6-K (1 November 2012)</a></p><p><a href="file.asp?id=2654">Teva: Form 6-K (filed 2 May 2014)</a></p><p><a href="file.asp?id=2655">Teva: Form 20-F (filed 9 February 2015)</a></p>
<!--
        	<a id="LogInLink" href="javascript:ShowLogin();">Click to log in.</a>

			<link rel="stylesheet" type="text/css" href="/compendium/includes/login.css" />
			
			<script type="text/javascript" src="/compendium/includes/login.js"></script>
			
			<div id="LoginForm" style="display: none">
				<iframe src="/compendium/includes/login.asp" align="center" width="300" height="300" frameborder="0" framebordercolor="transparent" scrolling="no" bgcolor="transparent" allowtransparency="true"></iframe>
			</div>
-->            
			
        
        <h2>CASE CATEGORIES</h2> 
        <span style="color: #006600;">Health Care</span><br /><span style="color: #ff99cc;">Ongoing U.S. FCPA Investigations</span><br />
    		<div class="footer">
	        &copy; 2015 TRACE International, Inc. 
	        </div>
		
    
    </div>

</div>
</body>
</html>
